Full Press Release Details
Alcon, Inc. Subsidiary
Announces Closing onSale
of Madrid, Spain Manufacturing Facility
HUNENBERG, Switzerland
November 6, 2003 Alcon, Inc. s (NYSE:ACL) wholly owned subsidiary, Alcon
CUS , S.A., today completed the sale of its contact lens care solutions
manufacturing facility located in Madrid, Spain to AMO Manufacturing Spain, S.L., a wholly
owned subsidiary of Advanced Medical Optics, Inc. (NYSE:AVO) for approximately $22
million. Alcon will realize a pre-tax gain of approximately $8 million from the sale,
which has been incorporated into the company s prior earnings guidance for the fourth
has committed to employ the facility s entire related work force. The production of
contact lens care products previously manufactured in Madrid has been transferred to the
Alcon plant in Fort Worth, Texas.
sale of this plant optimizes capacity levels, streamlines manufacturing and distribution
operations, gains efficiencies and reduces total production costs for contact lens care
solutions, said Andre Bens, Ph.D., Alcon senior vice president, Global Manufacturing
and Technical Support.
is the world s leading eye care company and has been dedicated to the ophthalmic
industry for more than 50 years. Alcon develops, manufactures and markets pharmaceuticals,
surgical equipment and devices, contact lens solutions and other vision care products that
treat diseases, disorders and other conditions of the eye.
Concerning Forward-Looking Statements. This press release contains forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of 1995,
relating principally to the completion of the sale of the Madrid plant. These statements
involve known and unknown risks, uncertainties and other factors which may cause our
actual results, performance or achievements to be materially different from any future
results, performances or achievements expressed or implied by our forward-looking
statements. These statements reflect the views of our management as of the date of this
press release with respect to future events and are based on assumptions and subject to
risks and uncertainties. Given these uncertainties, you should not place undue reliance on
these forward-looking statements. You should read this press release with the
understanding that our actual future results may be materially different from what we
expect. Except to the extent required under the federal securities laws and the rules and
regulations promulgated by the Securities and Exchange Commission, we undertake no
obligation to publicly update or revise any of these forward-looking statements, whether
to reflect new information or future events or circumstances or otherwise.
For information, contact:
MacHatton (Investor Relations)
News media and other inquiries: Mary Dulle (Public Relations)